SpringWorks Therapeutics

Filed a patent for "dosage forms of mirdametinib" on Thu, March 16, 2023

Filed a patent for "tetrahydronapthyridine and related analogs for inhibiting yap/taz-tead" on Tue, May 16, 2023

Filed a patent for "benzopiperazine and related analogs for inhibiting yap/taz-tead" on Tue, May 16, 2023

Filed a patent for "benzimidazole and related analogs for inhibiting yap/taz-tead" on Tue, May 16, 2023

Filed a patent for "dosage forms of mirdametinib" on Thu, September 19, 2024

Filed a patent for "dosage forms of mirdametinib" on Thu, September 19, 2024

Filed a patent for "compositions and treatments with nirogacestat" on Fri, May 3, 2024

Filed a patent for "mirdametinib treatment" on Thu, September 19, 2024

Filed a patent for "mirdametinib treatment" on Thu, September 19, 2024

Filed a patent for "mirdametinib treatment" on Thu, September 19, 2024

Filed a patent for "compositions and treatments with nirogacestat" on Thu, September 26, 2024

Filed a patent for "a combination therapy with nirogacestat and a bcma-directed therapy and uses thereof" on Thu, April 20, 2023

Filed a patent for "co-administration of mirdametinib and lifirafenib for use in treating cancers" on Thu, April 27, 2023

Filed a patent for "2-pyrazole anilines and related analogs for inhibiting yap/taz-tead" on Thu, September 7, 2023

Filed a patent for "dispersible formulations of n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2- fluoro-4-iodo-phenylamino)-benazmide and uses thereof" on Thu, October 19, 2023

Filed a patent for "treatment of ovarian cancer with nirogacestat" on Thu, August 3, 2023

Filed a patent for "treatment of pancreatic ductal adenocarcinoma with mirdametinib" on Thu, September 21, 2023

Filed a patent for "treatment of cutaneous neurofibromas with mirdametinib" on Thu, September 21, 2023

Filed a patent for "fluorinated phenylamino compounds and pharmaceutical compositions" on Thu, September 21, 2023

Filed a patent for "mirdametinib treatment" on Thu, October 12, 2023

Filed a patent for "treatment of neurofibromatosis type 1 (nf1) associated plexiform neurofibromas (pn) in pediatric patients with mirdametinib" on Thu, September 21, 2023

Filed a patent for "non-linear dosing of mirdametinib" on Thu, September 21, 2023

Filed a patent for "mirdametinib treatment" on Thu, September 21, 2023

Filed a patent for "synthesis of nirogacestat" on Thu, October 5, 2023

Filed a patent for "treatments with nirogacestat" on Thu, November 23, 2023